Conclusion
The findings of the Jordan AF study suggest that young patients (<50 years of age) with AF tend to have better baseline clinical characteristics, lower risk scores, and lower one-year mortality and major bleeding rates compared to older patients. Further studies are needed to confirm these findings and to determine the best management strategies for young AF patients.